Trials / Completed
CompletedNCT04369859
Obstetric and Perinatal Outcomes of Women With COVID-19
Obstetric and Perinatal Outcomes of Women With COVID-19: A Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 556 (actual)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently spreading rapidly around the globe, causing a major public health issue. There is currently very few data about the impact of COVID-19 on pregnancy, and potential in utero infection. This is a prospective observational study of COVID-19 diagnosed pregnant patients. This objective is to examine the impact of COVID-19 during pregnancy on the rates of obstetric and perinatal complications.
Detailed description
Clinical manifestations of COVID-19 can range from a benign upper respiratory tract infection to severe acute respiratory distress syndrome (ARDS), fatal in 1% of cases. However, pregnant women and their fetuses could particularly be vulnerable to the infection, as shown by previous human coronavirus outbreaks (SARS-CoV and MERS-CoV). Cases will be recruited among all pregnant women aged \>18 years old who have tested positive for COVID-19 and are followed in a maternity belonging to the French South Regional Perinatology Network. Voluntary physicians will refer eligible participants to the study-coordinating center at APHM University Hospital. The participants will be followed by phone after having provided an informed consent. Clinical symptoms, laboratory and imaging findings, maternal and perinatal outcomes will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Examine the impact of COVID-19 during pregnancy | clinical data collection |
Timeline
- Start date
- 2020-04-23
- Primary completion
- 2022-01-15
- Completion
- 2022-01-15
- First posted
- 2020-04-30
- Last updated
- 2022-02-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04369859. Inclusion in this directory is not an endorsement.